Search Results for: "Urogen pharma"

Investment in Israeli startups to 20/9/23

Posted on September 21, 2023

UroGen Pharma raised $120 million (Nasdaq) UBQ raised $70 million; FloLIVE raised $47 million; SQream raised $45 million; Prisma Photonics raised $20 million; Port.io raised $18 million; Zenity raised $16.5 million; ViAqua Therapeutics raised $8.25 million; Scala Biodesign raised $5.5 … Continue reading →

Posted in Economy & Business | Leave a comment

Positive results in bladder cancer trial

Posted on September 21, 2023

Israel’s UroGen Pharma (see here previously) has published positive results from two clinical trials of bladder cancer treatment UGN-102. The therapy can benefit some 80,000 patients. Trial success (65%) was similar to patients who had surgery but with a 55% … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Breakthrough treatment for urinary tract cancer

Posted on November 4, 2018

I reported previously (May 2017) that Israel’s UroGen Pharma had been granted FDA’s Orphan status for its treatment of malignant Upper Tract Urothelial Carcinoma. It has now received Breakthrough Therapy Designation status to help speed up development. http://investors.urogen.com/phoenix.zhtml?c=254372&p=irol-newsArticle&ID=2374119

Posted in Israel's Medical Achievements | Leave a comment

Cancer biotech launches on NASDAQ

Posted on May 14, 2017

Israel’s UroGen Pharma has three treatments for the treatment of cancers of the urinary system (bladder and kidneys). It has just raised $58.2 million on NASDAQ. UroGen’s MitoGel treatment for Upper Tract Urothelial Carcinoma has received Orphan status from the … Continue reading →

Posted in Israel's Medical Achievements | 1 Comment